Monashee Investment Management LLC Adaptive Biotechnologies Corp Transaction History

Monashee Investment Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$37.26 - $67.74 $1.12 Million - $2.03 Million	-30,000 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$45.01 - $65.47 $1.35 Million - $1.96 Million	30,000 New	30,000 $1.77 Million
Q3 2019 Nov 12, 2019	SELL	$30.31 - $53.51 $4.39 Million - $7.76 Million	-145,000 Closed	0 $0
Q2 2019 Aug 07, 2019	BUY	$40.3 - $48.3 $5.84 Million - $7 Million	145,000 New	145,000 $7 Million

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $849M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Monashee Investment Management LLC with notifications on news.